Dr.pharmacist
Pataday Once Daily

Pataday Once Daily

olopatadine

OTC DrugPataday Once Daily
Reviewed by Younghun Cho

Pharmacist's Verdict

Pataday Once Daily is a highly effective, prescription-strength antihistamine eye drop that offers fast, 24-hour relief from eye allergy symptoms, making it a top choice for those who need convenient and powerful relief.

Ingredient Analysis

Olopatadine 0.2%

Pros & Cons

Pros

  • Provides 24-hour relief with just one drop per day.
  • Contains a prescription-strength antihistamine for powerful relief.
  • Starts working in minutes to relieve itchy and red eyes.
  • Directly targets eye allergies at the source.

Cons

  • More expensive than some other over-the-counter allergy eye drops.
  • Can cause side effects like dry eyes, blurred vision, or an unusual taste in the mouth.
  • Must remove contact lenses before using and wait 10 minutes to reinsert.
  • Not intended for irritation caused by contact lenses.

Safety Information

Warnings

Warnings For external use only

Is Pataday Once Daily safe for you?

See pregnancy, interactions, and common concerns answered in our pharmacist safety FAQ.

Read safety review →

References

  1. 1.
    FDA Drug Label — Equate Olopatadine Hydrochloride Ophthalmic Solution

    FDA DailyMed: Equate Olopatadine Hydrochloride Ophthalmic Solution · FDA

  2. 2.
    FDA Drug Label — PATADAY ONCE DAILY RELIEF

    FDA DailyMed: PATADAY ONCE DAILY RELIEF · FDA

  3. 3.
    Allergic Rhinitis: A Review.

    Bernstein JA, Bernstein JS, Makol R, et al., JAMA, 2024 · PubMed

  4. 4.
    Olopatadine.

    , 2006 · PubMed

  5. 5.
    Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management.

    Ackerman S, Smith LM, Gomes PJ, Therapeutic advances in chronic disease, 2016 · PubMed

  6. 6.
    Comparative Efficacy and Acceptability of Licensed Dose Second-Generation Antihistamines in Chronic Spontaneous Urticaria: A Network Meta-Analysis.

    Phinyo P, Koompawichit P, Nochaiwong S, et al., The journal of allergy and clinical immunology. In practice, 2021 · PubMed